Skip to main content
. 2020 Dec 22;181(4):471–478. doi: 10.1001/jamainternmed.2020.8193

Table 1. Hospital and Patient Characteristicsa.

Characteristic Total sample Analysis of early and late periods
Both periods Early period, January 1-April 30, 2020 Late period, May 1-June 30, 2020
Patients, No. 38 517 27 801 10 428 17 373
Hospitals, No. 955 398 398 398
Patient-level characteristics
Age, mean (SD), y 70.2 (15.5) 70.9 (15.2) 70.9 (15.1) 70.9 (15.3)
Age range, y
18-45 2802 (7.3) 1855 (6.7) 691 (6.6) 1164 (6.7)
45-55 2891 (7.5) 1912 (6.9) 735 (7.0) 1177 (6.8)
55-65 5867 (15.2) 3916 (14.1) 1453 (13.9) 2463 (14.2)
65-75 10 283 (26.7) 7621 (27.4) 2903 (27.8) 4718 (27.2)
75-85 9863 (25.6) 7445 (26.8) 2776 (26.6) 4669 (26.9)
≥85 6811 (17.7) 5052 (18.2) 1870 (17.9) 3182 (18.3)
Male sex 18 888 (49.0) 13 552 (48.7) 5230 (50.2) 8322 (47.9)
Mean Elixhauser score (SD) 8.5 (11.0) 8.8 (11.2) 8.9 (11.3) 8.7 (11.1)
Elixhauser comorbidities
Iron deficiency anemia 12 420 (32.2) 9266 (33.3) 3614 (34.7) 5652 (32.5)
Blood loss anemia 1574 (4.1) 1159 (4.2) 428 (4.1) 731 (4.2)
Congestive heart failure 9663 (25.1) 7171 (25.8) 2708 (26.0) 4463 (25.7)
Chronic obstructive pulmonary disease 12 654 (32.9) 9117 (32.8) 3467 (33.2) 5650 (32.5)
Coagulopathy 2786 (7.2) 2119 (7.6) 784 (7.5) 1335 (7.7)
Depression 8188 (21.3) 5876 (21.1) 2194 (21.0) 3682 (21.2)
Diabetes without chronic complications 14 139 (36.7) 10 275 (37.0) 3987 (38.2) 6288 (36.2)
Diabetes with chronic complications 12 148 (31.5) 8857 (31.9) 3426 (32.9) 5431 (31.3)
Substance use disorder 1437 (3.7) 1036 (3.7) 379 (3.6) 657 (3.8)
Hypertension 29 335 (76.2) 21 413 (77.0) 8004 (76.8) 13 409 (77.2)
Hypothyroidism 8096 (21.0) 5900 (21.2) 2305 (22.1) 3595 (20.7)
Lymphoma 734 (1.9) 591 (2.1) 229 (2.2) 362 (2.1)
Fluid and electrolyte disorder 10 238 (26.6) 7541 (27.1) 2811 (27.0) 4730 (27.2)
Metastatic cancer 1456 (3.8) 1092 (3.9) 396 (3.8) 696 (4.0)
Neurological disorder 9048 (23.5) 6615 (23.8) 2555 (24.5) 4060 (23.4)
Obesity 10 100 (26.2) 7156 (25.7) 2702 (25.9) 4454 (25.6)
Paralysis 1938 (5.0) 1396 (5.0) 570 (5.5) 826 (4.8)
Peripheral vascular disease 9899 (25.7) 7430 (26.7) 2952 (28.3) 4478 (25.8)
Psychosis 2578 (6.7) 1887 (6.8) 766 (7.3) 1121 (6.5)
Chronic kidney disease 9832 (25.5) 7346 (26.4) 2760 (26.5) 4586 (26.4)
Solid tumor without metastasis 5352 (13.9) 4042 (14.5) 1455 (14.0) 2587 (14.9)
Valvular disorder 7723 (20.1) 5778 (20.8) 2099 (20.1) 3679 (21.2)
Weight loss 3528 (9.2) 2661 (9.6) 1036 (9.9) 1625 (9.4)
Transferred from a nursing facility 4244 (11.0) 3034 (10.9) 1690 (16.2) 1344 (7.7)
Insurance type
Medicare Advantage 29 081 (75.5) 21 716 (78.1) 8047 (77.2) 13 669 (78.7)
Commercial 9436 (24.5) 6085 (21.9) 2381 (22.8) 3704 (21.3)
Hospital-level characteristics
Hospital size
0-150 Beds 222 (23.2) 63 (15.8) NA NA
150-300 Beds 336 (35.2) 121 (30.4)
300-450 Beds 194 (20.3) 88 (22.1)
≥450 Beds 203 (21.3) 126 (31.7)
No. of ICU beds
0-20 319 (33.4) 107 (26.9) NA NA
20-60 346 (36.2) 135 (33.9)
≥60 290 (30.4) 156 (39.2)
Hospital setting
Urban 892 (93.4) 385 (96.7) NA NA
Nonurban 63 (6.6) 13 (3.3)
Hospital region
Northeast 264 (27.6) 126 (31.7) NA NA
South 285 (29.8) 133 (33.4)
Midwest 315 (33.0) 113 (28.4)
West 91 (9.5) 26 (6.5)
Profit status
Nonprofit 705 (73.8) 307 (77.1) NA NA
For profit 139 (14.6) 46 (11.6)
Other 111 (11.6) 45 (11.3)
Academic hospital 154 (16.1) 94 (23.6) NA NA

Abbreviations: ICU, intensive care unit; NA, not applicable.

a

Unless otherwise indicated, data are reported as number (percentage) of patients.